(L12) Pemphigoid

More details coming soon

Icon
231 237 in individuals diagnosis pemphigoid confirmed
Icon
8 706 deaths with diagnosis pemphigoid
Icon
4% mortality rate associated with the disease pemphigoid

Diagnosis pemphigoid is diagnosed Women are 18.79% more likely than Men

93 894

Men receive the diagnosis pemphigoid

3 346 (3.6 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
137 343

Women receive the diagnosis pemphigoid

5 360 (3.9 %)

Died from this diagnosis.

Risk Group for the Disease pemphigoid - Men and Women aged 80-84

Icon
In Men diagnosis is most often set at age 0-14, 25-95+
Icon
Less common in men the disease occurs at Age 15-24in in women, the disease manifests at any age
Icon
In Women diagnosis is most often set at age 0-95+

Disease Features pemphigoid

Icon
Non-contagious
Icon
Absence or low individual and public risk
Icon

Pemphigoid - what does this mean

Pemphigoid is an autoimmune disorder in which the body's immune system mistakenly attacks healthy tissue, leading to inflammation and blistering of the skin and mucous membranes. it is caused by the production of autoantibodies which bind to proteins in the basement membrane, resulting in cell death and blister formation.

What happens during the disease - pemphigoid

More details coming soon

Clinical Pattern

More details coming soon

How does a doctor diagnose

  • Complete physical examination
  • Skin biopsy
  • Blood tests to check for autoantibodies
  • Skin prick test
  • Patch test
  • Scraping and culture of skin lesions
  • CT scan or MRI
  • X-ray

Treatment and Medical Assistance

Main goal of the treatment: To reduce the severity of the symptoms and prevent further damage from the disease.
  • Prescribing topical and oral medications to reduce inflammation and itchiness.
  • Using corticosteroid creams to reduce inflammation.
  • Prescribing oral steroids to reduce inflammation and suppress the immune system.
  • Prescribing immunosuppressant medications to reduce the activity of the immune system.
  • Prescribing topical medications to reduce inflammation and blistering.
  • Prescribing oral immunomodulators to reduce the activity of the immune system.
  • Using phototherapy to reduce inflammation.
  • Using laser therapy to reduce inflammation.
  • Using biologic agents to reduce inflammation.
  • Using antibiotics to reduce infection.
  • Using dietary modifications to reduce inflammation.
Icon
22 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Pemphigoid - Prevention

Pemphigoid can be prevented by avoiding exposure to irritants, allergens, and environmental triggers such as certain medications, ultraviolet light, and extreme temperatures. it is also important to practice good hygiene and to keep skin moisturized. additionally, it is important to seek medical advice and treatment for any skin condition that may be associated with pemphigoid, as early diagnosis and treatment can reduce the risk of developing the condition.

Specified forms of the disease

(L12.0) Bullous pemphigoid
(L12.1) Cicatricial pemphigoid
(L12.2) Chronic bullous disease of childhood
(L12.3) Acquired epidermolysis bullosa
(L12.8) Other pemphigoid
(L12.9) Pemphigoid, unspecified